Skip to main content
. 2019 Aug 5;21(11):2474–2485. doi: 10.1111/dom.13830

Table 1.

Patient baseline characteristics, overall and by region

Total Africa Americas South‐East Asia Europe Eastern Mediterranean Western Pacific
(N = 14 668) (n = 811) (n = 2002) (n = 3351) (n = 3470) (n = 2179) (n = 2855)
Proportion of patients, % 100.0 5.5 13.6 22.8 23.7 14.9 19.5
Sex, male 7909 (53.9) 305 (37.6) 963 (48.1) 1846 (55.1) 1853 (53.5) 1278 (58.7) 1664 (58.3)
Missing 4 0 0 0 4 0 0
Age, years, mean (SD) 57.5 (12.0) 54.9 (11.2) 58.3 (11.8) 53.1 (11.3) 61.9 (10.9) 53.8 (10.8) 60.1 (12.7)
Missing 0 0 0 0 0 0 0
Self‐reported ethnicity
Caucasian 3911 (27.9) 105 (13.0) 480 (29.4) 1 (0.0) 3014 (94.8) 165 (7.6) 146 (5.1)
Black 310 (2.2) 235 (29.0) 61 (3.7) 0 (0.0) 13 (0.4) 0 (0.0) 1 (0.0)
Asian 6299 (45.0) 177 (21.9) 9 (0.6) 3330 (99.5) 20 (0.6) 72 (3.3) 2691 (94.3)
Hispanic 942 (6.7) 1 (0.1) 928 (56.8) 0 (0.0) 11 (0.3) 0 (0.0) 2 (0.1)
Arabic 2147 (15.3) 199 (24.6) 4 (0.2) 2 (0.1) 12 (0.4) 1930 (88.9) 0 (0.0)
Mixed 213 (1.5) 91 (11.2) 115 (7.0) 0 (0.0) 4 (0.1) 0 (0.0) 3 (0.1)
Other 174 (1.2) 2 (0.2) 36 (2.2) 15 (0.4) 104 (3.3) 5 (0.2) 12 (0.4)
Missing 672 1 369 3 292 7 0
Education
No formal education 405 (3.0) 57 (7.3) 50 (3.2) 26 (0.8) 78 (2.5) 158 (7.7) 36 (1.4)
Primary (1‐6 years) 2059 (15.5) 182 (23.2) 442 (28.7) 342 (10.3) 586 (19.1) 360 (17.6) 147 (5.7)
Secondary (7‐13 years) 6600 (49.5) 420 (53.6) 587 (38.1) 1427 (43.2) 1778 (58.0) 765 (37.5) 1623 (62.8)
Higher education (>13 years) 4258 (32.0) 125 (15.9) 463 (30.0) 1510 (45.7) 623 (20.3) 758 (37.1) 779 (30.1)
Missing 1346 27 460 46 405 138 270
Main working status
Employed 5046 (36.7) 262 (32.7) 473 (29.9) 875 (26.2) 1094 (34.1) 952 (45.5) 1408 (50.8)
Self‐employed 1679 (12.2) 59 (7.4) 343 (21.7) 751 (22.5) 170 (5.3) 209 (10.0) 147 (5.3)
Disabled 82 (0.6) 6 (0.7) 6 (0.4) 0 (0.0) 59 (1.8) 2 (0.1) 9 (0.3)
Not working 4009 (29.1) 336 (41.9) 428 (27.1) 1385 (41.4) 505 (15.8) 683 (32.6) 672 (24.3)
Retired 2892 (21.0) 139 (17.3) 330 (20.9) 332 (9.9) 1378 (43.0) 247 (11.8) 466 (16.8)
Other 67 (0.5) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 67 (2.4)
Missing 875 9 422 8 264 86 86
Health insurance coverage
Private 2021 (14.7) 165 (20.7) 517 (32.3) 592 (18.8) 130 (3.9) 466 (22.3) 151 (5.4)
Public/government 8249 (59.8) 465 (58.2) 783 (48.8) 371 (11.8) 3038 (91.3) 1226 (58.7) 2366 (84.0)
Mixed 354 (2.6) 16 (2.0) 137 (8.5) 51 (1.6) 26 (0.8) 69 (3.3) 55 (2.0)
No insurance 3163 (22.9) 153 (19.1) 166 (10.4) 2140 (67.9) 134 (4.0) 327 (15.7) 243 (8.6)
Missing 881 12 399 197 142 91 40
Years since type 2 diabetes diagnosis, mean (SD) 5.7 (5.3) 6.9 (5.7) 6.2 (6.1) 4.6 (4.1) 6.6 (5.4) 5.8 (5.1) 5.4 (5.6)
Missing 394 0 63 1 151 3 176
HbA1c, %, mean (SD) 8.3 (1.7) 8.6 (1.9) 8.5 (1.9) 8.6 (1.7) 8.1 (1.6) 8.7 (1.6) 7.9 (1.6)
Missing 2799 345 471 1307 470 135 71
BMI, kg/m2, mean (SD) 29.4 (6.0) 30.6 (6.2) 30.6 (6.1) 27.3 (4.5) 31.9 (6.1) 31.1 (5.7) 26.5 (5.4)
Missing 1150 13 202 207 258 324 146
Microvascular complicationsa 2843 (19.4) 118 (14.5) 302 (15.1) 556 (16.6) 808 (23.4) 398 (18.3) 661 (23.2)
Missing 18 0 0 0 18 0 0
Macrovascular complicationsb 2147 (14.7) 78 (9.6) 276 (13.8) 140 (4.2) 1045 (30.5) 236 (10.8) 372 (13.0)
Missing 42 0 0 0 42 0 0
History of major hypoglycaemiac 133 (1.0) 11 (1.4) 26 (1.6) 15 (0.5) 44 (1.3) 22 (1.1) 15 (0.5)
Missing 951 34 415 102 130 225 45
History of minor hypoglycaemiad 479 (3.5) 43 (5.5) 41 (2.6) 83 (2.6) 116 (3.5) 147 (7.4) 49 (1.7)
Missing 903 26 410 104 119 205 39

Data are n (%) unless otherwise indicated. Percentages were calculated for all patients with data available; patients with missing data were excluded.

Abbreviations: BMI, body mass index; SD, standard deviation.

a

Composite of nephropathy, retinopathy and neuropathy.

b

Composite of coronary heart disease, cerebrovascular disease, peripheral artery disease, heart failure and implantable cardioverter defibrillator use.

c

Hypoglycaemic events requiring external/third party assistance in the previous year.

d

Hypoglycaemic events that were self‐reported, and which occurred in the previous 4 weeks.